Rxsight, Inc. (RXST)
NASDAQ:RXST
Want to see RXST full AI Analyst Report?
Total Valuation
RxSight has a market cap or net worth of $248.38M. The enterprise value is $239.56M.
Market Cap$248.38M
Enterprise Value$239.56M
Share Statistics
RxSight has 41,396,610 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding41,396,610
Owned by Insiders5.57%
Owned by Institutions23.90%
Financial Efficiency
RxSight’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -16.81%.
Return on Equity (ROE)-0.14
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-16.81%
Return on Capital Employed (ROCE)-0.17
Revenue Per Employee270.03K
Profits Per Employee0.00
Employee Count498
Asset Turnover0.43
Inventory Turnover1.00
Valuation Ratios
The current PE Ratio of RxSight is ―. RxSight’s PEG ratio is -0.33.
PE Ratio―
PS Ratio3.19
PB Ratio1.56
Price to Fair Value1.56
Price to FCF-22.18
Price to Operating Cash Flow-13.99
PEG Ratio-0.33
Income Statement
In the last 12 months, RxSight had revenue of 134.48M and earned -38.94M in profits. Earnings per share was -0.95.
Revenue134.48M
Gross Profit103.01M
Operating Income-48.19M
Pretax Income-38.88M
Net Income-38.94M
EBITDA-39.62M
Earnings Per Share (EPS)-0.95
Cash Flow
In the last 12 months, operating cash flow was -17.57M and capital expenditures -4.01M, giving a free cash flow of -21.58M billion.
Operating Cash Flow-17.57M
Free Cash Flow-21.58M
Free Cash Flow per Share-0.52
Dividends & Yields
RxSight pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.30
52-Week Price Change-64.20%
50-Day Moving Average6.78
200-Day Moving Average8.68
Relative Strength Index (RSI)40.18
Average Volume (3m)702.22K
Important Dates
RxSight upcoming earnings date is Aug 10, 2026, After Close (Confirmed).
Last Earnings DateMay 6, 2026
Next Earnings DateAug 10, 2026
Ex-Dividend Date―
Financial Position
RxSight as a current ratio of 10.95, with Debt / Equity ratio of 4.05%
Current Ratio10.95
Quick Ratio9.75
Debt to Market Cap0.03
Net Debt to EBITDA0.22
Interest Coverage Ratio-1.20K
Taxes
In the past 12 months, RxSight has paid 66.00K in taxes.
Income Tax66.00K
Effective Tax Rate>-0.01
Enterprise Valuation
RxSight EV to EBITDA ratio is -10.60, with an EV/FCF ratio of -21.72.
EV to Sales3.12
EV to EBITDA-10.60
EV to Free Cash Flow-21.72
EV to Operating Cash Flow-27.09
Balance Sheet
RxSight has $217.88M in cash and marketable securities with $10.83M in debt, giving a net cash position of $207.05M billion.
Cash & Marketable Securities$217.88M
Total Debt$10.83M
Net Cash$207.05M
Net Cash Per Share$5.00
Tangible Book Value Per Share$6.70
Margins
Gross margin is 77.02%, with operating margin of -35.84%, and net profit margin of -28.96%.
Gross Margin77.02%
Operating Margin-35.84%
Pretax Margin-28.91%
Net Profit Margin-28.96%
EBITDA Margin-29.46%
EBIT Margin-28.88%
Analyst Forecast
The average price target for RxSight is $9.83, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$9.83
Price Target Upside29.22% Upside
Analyst ConsensusHold
Analyst Count9
Revenue Growth Forecast-14.05%
EPS Growth Forecast-70.35%